» Articles » PMID: 39946025

Perspectives on Stringent Glycemic Control and Weight Loss Among Patients with Type 2 Diabetes in China: A Survey Study

Overview
Journal Diabetes Ther
Date 2025 Feb 13
PMID 39946025
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Although current guidelines for type 2 diabetes (T2D) underscored the importance of attaining glycemic control and weight management goals, the patient perspectives on achieving these goals remained unclear in China. This study aimed to understand Chinese patients' perspectives on stringent glycemic control (hemoglobin A1c [HbA1c] ≤ 6.5%) and weight loss (≥ 10%) and their treatment preferences.

Methods: Adult Chinese patients diagnosed with T2D who were aware of their latest HbA1c were enrolled in this survey study. An electronic questionnaire was designed to collect patients' characteristics, perspectives on safely achieving stringent glycemic control and weight loss, and preferences for different T2D treatment profiles.

Results: The study included 495 patients. Patients predominantly indicated that safely achieving stringent glycemic control was extremely (82.83%) or moderately (12.12%) important. Nearly half of the patients (n = 231) perceived ≥ 10% weight loss as beneficial, among whom 117 (50.65%) and 84 (36.36%) indicated it was extremely and moderately important, respectively. Both having HbA1c > 6.5% within the past 6 months and body mass index ≥ 24 kg/m were associated with increased odds of choosing the T2D treatment with a higher chance of achieving stringent glycemic control and weight loss, given a similar safety profile. Conversely, age ≥ 60 years was associated with decreased odds of having the outcomes listed above.

Conclusion: This study demonstrated that most surveyed patients with T2D in China recognized the importance of safely achieving stringent glycemic control and weight loss. The identified factors associated with patients' perspectives and preferences could benefit clinical decision-making.

References
1.
Wang L, Peng W, Zhao Z, Zhang M, Shi Z, Song Z . Prevalence and Treatment of Diabetes in China, 2013-2018. JAMA. 2021; 326(24):2498-2506. PMC: 8715349. DOI: 10.1001/jama.2021.22208. View

2.
Yuan H, Li X, Wan G, Sun L, Zhu X, Che F . Type 2 diabetes epidemic in East Asia: a 35-year systematic trend analysis. Oncotarget. 2018; 9(6):6718-6727. PMC: 5805508. DOI: 10.18632/oncotarget.22961. View

3.
Wing R, Lang W, Wadden T, Safford M, Knowler W, Bertoni A . Benefits of modest weight loss in improving cardiovascular risk factors in overweight and obese individuals with type 2 diabetes. Diabetes Care. 2011; 34(7):1481-6. PMC: 3120182. DOI: 10.2337/dc10-2415. View

4.
Strelitz J, Ahern A, Long G, Hare M, Irving G, Boothby C . Moderate weight change following diabetes diagnosis and 10 year incidence of cardiovascular disease and mortality. Diabetologia. 2019; 62(8):1391-1402. PMC: 6647260. DOI: 10.1007/s00125-019-4886-1. View

5.
Agrawal L, Azad N, Bahn G, Ge L, Reaven P, Hayward R . Long-term follow-up of intensive glycaemic control on renal outcomes in the Veterans Affairs Diabetes Trial (VADT). Diabetologia. 2017; 61(2):295-299. PMC: 5747983. DOI: 10.1007/s00125-017-4473-2. View